Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not

Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not

Introduction: Adolescents and young adults are the primary reservoirs and transmitters of meningococci. In the US, meningococcal serogroup B (MenB) disease predominates over A, C, W, and Y; ACIP-recommended MenACWY and MenB vaccines are available. We investigated invasive meningococcal disease (IMD)...

Full description

Saved in:
Bibliographic Details
Published in:Postgraduate medicine Vol. 131; no. 8; pp. 551 - 554
Main Authors: Alderfer, Justine T., Moran, Mary M., Srivastava, Amit, Isturiz, Raul E.
Format: Journal Article
Language:English
Published: England Taylor & Francis 17-11-2019
Subjects:
Adolescent
adolescents
college
Decision Making
epidemiology
Female
Humans
Male
Meningococcal Infections - epidemiology
Meningococcal Infections - prevention & control
Meningococcal serogroup B
Meningococcal Vaccines - administration & dosage
Neisseria meningitidis
Patient Participation
Practice Patterns, Physicians
prevention and control
United States
vaccination
Vaccination Coverage - statistics & numerical data
Young Adult
United States
college
Meningococcal serogroup B
epidemiology
prevention and control
adolescents
vaccination
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Adolescents and young adults are the primary reservoirs and transmitters of meningococci. In the US, meningococcal serogroup B (MenB) disease predominates over A, C, W, and Y; ACIP-recommended MenACWY and MenB vaccines are available. We investigated invasive meningococcal disease (IMD) burden and vaccination among non-college adolescents. Methods: IMD incidence by college attendance status and vaccination rates were analyzed using publicly available surveillance data. Results: 64/158 IMD cases occurred in non-college 18-24-year-olds during 2015-2017. Among non-college cases, the MenACWY vaccination rates were 38%-57% vs 90%-100% among college cases when vaccination status was known; MenB vaccination was 0% vs 0%-7%, respectively. In 2018, 17.2% of all 17-year-olds received ≥1 dose of multidose MenB vaccines; ≤50% completed the series. Conclusion: Meningococcal vaccination is emphasized for college-bound adolescents, but non-college adolescents bear much of the disease burden. Low vaccine receipt preserves their risk, underscoring the need to protect all adolescents through vaccination.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0032-5481
1941-9260
DOI:10.1080/00325481.2019.1671667